List of articles in "Drug" category - Page 210

Tolevamer is a toxin binding polymer that was investigated by Genzyme for the treatment of Clostridium difficile associated diarrhoea (CDAD).

Paricalcitol (chemically it is 19-nor-125-(OH)2-vitamin D2. Marketed by Abbott Laboratories under the trade name Zemplar) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of […]

Leteprinim (Neotrofin AIT-082) is a hypoxanthine derivative drug with neuroprotective and nootropic effects. It stimulates release of nerve growth factors and enhances survival of neurons in the brain and is […]

Roflumilast (trade names Daxas Daliresp) is a drug which acts as a selective long-acting inhibitor of the enzyme PDE-4. It has anti-inflammatory effects and is under development as an orally […]

Teriflunomide (trade name Aubagio marketed by Sanofi also known as A77 1726) is the active metabolite of leflunomide. Teriflunomide was investigated in the Phase III clinical trial TEMSO as a […]

RPL-554 (LS-193855) is a drug which acts as a long-acting inhibitor of the phosphodiesterase enzymes PDE-3 and PDE-4 producing both bronchodilator and antiinflammatory effects. It is being developed by Verona […]

Interferon alfa (INN or HuIFN-alpha-Le) trade name Multiferon is a natural interferon alpha (IFN-α) which is obtained from the leukocyte fraction of human blood following induction with Sendai virus. Interferon […]

Cardanol is a phenolic lipid obtained from anacardic acid the main component of cashew nutshell liquid (CNSL) a byproduct of cashew nut processing. Cardanol finds use in the chemical industry […]

Ciclacillin (INN) or cyclacillin (USAN) trade names Cyclapen Cyclapen-W Vastcillin and others is an aminopenicillin antibiotic. Its spectrum of activity is similar to that of ampicillin although it is less […]

Aplindore (DAB-452) is a drug which acts as a partial agonist selective for the dopamine receptor D2. It is being developed by the pharmaceutical company Neurogen as a treatment for […]